Features

Management of Oligometastatic PCa

More and more cases of oligometastatic PCa are being diagnosed as a result of advances in molecular imaging, but clinical trial data about the best ...

Avoid Biopsy for Elevated PSA?

Multiparametric magnetic resonance imaging in conjunction with transrectal ultrasound-guided biopsy improves discrimination between clinically significant and insignificant prostate tumors and can spare patients unnecessary biopsies.

3D Printed Prostates Could Improve RP

New technique uses silicone-based polymer inks to create prostate models with the tactile sensation, pliability, and texture of a real prostate.

Outpatient Transperineal Prostate Biopsy

The transperineal approach to prostate biopsy has recently been adopted at many centers as an alternative to TRUS-B.

PET/CT for Prostate Cancer

Novel PET radiotracers have shown great potential in the early diagnosis and staging of PCa, detection of post-treatment recurrence, and monitoring of metastases not previously ...

RP vs Radiation for High-Risk PCa

Physicians who treat patients with high-risk prostate cancer remain uncertain as to the optimal treatment approach, in part due to difficulty in interpreting study data.

New PCa Grading System Embraced

Endorsed by the International Society of Urological Pathology in 2014, the 5-tier Gleason grade group system is used routinely today in pathology reports and physician ...

Overuse of PCa Scans May Be Easing

Efforts by physician groups in recent years to discourage inappropriate use of radiologic imaging for the initial staging of men with newly diagnosed low-risk disease ...

The Role of MRI in Prostate Cancer Management

An interview with Ashutosh K. Tewari, MBBS, MCh

Latest Prostate Cancer News

Cancer Screening More Likely After a Previous False Positive

Cancer Screening More Likely After a Previous False Positive

Findings for both men and women with a false-positive prostate or breast cancer test result.

BRCA Mutations Up Risk for PCa, Other Cancers

BRCA Mutations Up Risk for PCa, Other Cancers

Increased incidence of malignant disease, specifically prostate, melanoma, pancreas, breast cancers

Survey Highlights Emotional Responses to Prostate Cancer

Survey Highlights Emotional Responses to Prostate Cancer

Sexual dysfunction was a chief complaint among survey respondents with prostate cancer.

Myocarditis Rare Side Effect of Immune Checkpoint Inhibitors

Myocarditis Rare Side Effect of Immune Checkpoint Inhibitors

Myocarditis with ICIs may be more common than initially thought; responds to higher steroid dosages

Diet, Exercise With Behavioral Counseling Can Reduce ADT Side Effects

Diet, Exercise With Behavioral Counseling Can Reduce ADT Side Effects

A novel component of an interventional program was cognitive-behavioral counseling administered in a group setting to promote behavioral change.

Socioeconomics May Not Explain Racial Gap in Prostate Cancer Mortality

Socioeconomics May Not Explain Racial Gap in Prostate Cancer Mortality

In a study, race independently predicted prostate cancer-specific mortality beyond a number of risk factors, including health insurance status.

Low-Dose Abiraterone Noninferior for Castration-Resistant PCa

Low-Dose Abiraterone Noninferior for Castration-Resistant PCa

Low-dose AA with low-fat breakfast had greater effect on PSA; similar effect to standard dose

Adjuvant RT Plus ADT Beneficial in Selected Prostate Cancer Cases

Adjuvant RT Plus ADT Beneficial in Selected Prostate Cancer Cases

Study identifies which PCa patients with positive lymph nodes may have improved survival with the addition of adjuvant radiotherapy to androgen-deprivation therapy.

Biopsy-to-RP Delay May Up Prostate Cancer Recurrence Risk

Biopsy-to-RP Delay May Up Prostate Cancer Recurrence Risk

Researchers concluded that a greater than 90-day interval from prostate biopsy to radical prostatectomy increases the risk of biochemical recurrence among men with Gleason 3+4 disease.

Metastatic Prostate Cancer at Diagnosis in Decline

Metastatic Prostate Cancer at Diagnosis in Decline

Study documents a drop in the incidence of de novo metastatic PCa from 1980 to 2011 in the United States.

Finasteride Cuts Prostate Cancer Risk Long Term

Finasteride Cuts Prostate Cancer Risk Long Term

New study shows that men are at lower risk of prostate cancer for years after they stop taking the medication.

MRI Scans Can Avert Many Prostate Biopsies

MRI Scans Can Avert Many Prostate Biopsies

In a large international trial, pre-biopsy MRI scans spared 28% of men from having to undergo a biopsy and resulted in a lower detection of clinically insignificant cancers vs standard biopsy.

Dose-Escalated RT Does Not Improve Survival in Intermediate-Risk PCa

Dose-Escalated RT Does Not Improve Survival in Intermediate-Risk PCa

Researchers observed reductions in biochemical failure and distant metastasis rates in patients who had dose-escalated radiation therapy.

No Advantages With Aggressive Treatment in Metastatic Prostate Cancer

No Advantages With Aggressive Treatment in Metastatic Prostate Cancer

However, mortality higher with conservative therapy in locally advanced, non-metastatic prostate cancer.

Single PSA Screening Has No Effect on Prostate Cancer Mortality

Single PSA Screening Has No Effect on Prostate Cancer Mortality

Findings from a large study of men in the United Kingdom do not support single PSA testing for population-based screening.

Sign up for free e-Newsletters